Literature DB >> 24116950

Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation.

Wojciech G Lesniak1, Manoj K Mishra, Amar Jyoti, Bindu Balakrishnan, Fan Zhang, Elizabeth Nance, Roberto Romero, Sujatha Kannan, Rangaramanujam M Kannan.   

Abstract

Dendrimers are being explored in many preclinical studies as drug, gene, and imaging agent delivery systems. Understanding their detailed organ, tissue, cellular uptake, and retention can provide valuable insights into their effectiveness as delivery vehicles and the associated toxicity. This work explores a fluorescence-quantification based assay that enables simultaneous quantitative biodistribution and imaging of dendrimers with a single agent. We have labeled an ethylenediamine-core generation-4 hydroxyl-terminated poly(amidoamine) (PAMAM) dendrimer using the fluorescent photostable, near-IR cyanine dye (Cy5) and performed quantitative and qualitative biodistribution of the dendrimer-Cy5 conjugates (D-Cy5) in healthy neonatal rabbits and neonatal rabbits with cerebral palsy (CP). The biodistribution of D-Cy5 and free Cy5 dye was evaluated in newborn rabbits, based on the developed quantification methods using fluorescence spectroscopy, high-performance liquid chromatography (HPLC), and size exclusion chromatography (SEC) and supported by microscopic imaging. The uptake was assessed in the brain, heart, liver, lungs, kidneys, blood serum, and urine. Results obtained based on these three independent methods are in good agreement and indicate the fast renal clearance of D-Cy5 and free Cy5 with relatively higher organs accumulation of the D-Cy5 conjugate. Following systemic administration, the D-Cy5 mainly accumulated in kidneys and bladder at 24 h. The quantitative biodistribution is in good agreement with previous studies based on radiolabeling. These methods for dendrimers quantification are easier and more practical, provide excellent sensitivity (reaching 0.1 ng per gram of tissue), and allow for quantification of dendrimers in different organs over longer time periods without concerns for radioactive decay, while also enabling tissue and cellular imaging in the same animal. In kits with fetal-neuroinflammation induced CP, there was a significantly higher uptake of D-Cy5 in the brain, while biodistribution in other organs was similar to that of healthy kits.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24116950      PMCID: PMC3977004          DOI: 10.1021/mp400371r

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  39 in total

Review 1.  In vivo methods to study uptake of nanoparticles into the brain.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Wim E Hennink; Gert Storm; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-10-07       Impact factor: 4.200

2.  Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration.

Authors:  Hui Dai; Raghavendra S Navath; Bindu Balakrishnan; Bharath Raja Guru; Manoj K Mishra; Roberto Romero; Rangaramanujam M Kannan; Sujatha Kannan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

3.  Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin.

Authors:  B Klajnert; M Bryszewska
Journal:  Bioelectrochemistry       Date:  2002-01       Impact factor: 5.373

4.  Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

Authors:  Pilar Calvo; Bruno Gouritin; Henri Villarroya; Françoise Eclancher; Claudia Giannavola; Christophe Klein; Jean P Andreux; Patrick Couvreur
Journal:  Eur J Neurosci       Date:  2002-04       Impact factor: 3.386

5.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Authors:  N Malik; R Wiwattanapatapee; R Klopsch; K Lorenz; H Frey; J W Weener; E W Meijer; W Paulus; R Duncan
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

6.  Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Sang-Kyung Jo; Noriko Sato; Tsuneo Saga; Akira Hiraga; Junji Konishi; Susan Hu; Kaori Togashi; Martin W Brechbiel; Robert A Star
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

7.  Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation.

Authors:  Sunil Shaunak; Sharyn Thomas; Elisabetta Gianasi; Antony Godwin; Emma Jones; Ian Teo; Kamiar Mireskandari; Philip Luthert; Ruth Duncan; Steve Patterson; Peng Khaw; Steve Brocchini
Journal:  Nat Biotechnol       Date:  2004-07-18       Impact factor: 54.908

8.  3H dendrimer nanoparticle organ/tumor distribution.

Authors:  Shraddha S Nigavekar; Lok Yun Sung; Mikel Llanes; Areej El-Jawahri; Theodore S Lawrence; Christopher W Becker; Lajos Balogh; Mohamed K Khan
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

9.  Targeting hepatic cancer cells with pegylated dendrimers displaying N-acetylgalactosamine and SP94 peptide ligands.

Authors:  Scott H Medina; Gopinath Tiruchinapally; Maxim V Chevliakov; Yasemin Yuksel Durmaz; Rachell N Stender; William D Ensminger; Donna S Shewach; Mohamed E H Elsayed
Journal:  Adv Healthc Mater       Date:  2013-04-03       Impact factor: 9.933

10.  Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation.

Authors:  Admira Bosnjakovic; Manoj K Mishra; Weiping Ren; Yunus E Kurtoglu; Tong Shi; Dianna Fan; Rangaramanujam M Kannan
Journal:  Nanomedicine       Date:  2010-11-06       Impact factor: 5.307

View more
  49 in total

1.  Is an episode of suspected preterm labor that subsequently leads to a term delivery benign?

Authors:  Roberto Romero; Offer Erez; Eli Maymon; Percy Pacora
Journal:  Am J Obstet Gynecol       Date:  2017-02       Impact factor: 8.661

2.  Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model.

Authors:  Anjali Sharma; Joshua E Porterfield; Elizabeth Smith; Rishi Sharma; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2018-06-05       Impact factor: 9.776

Review 3.  Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics.

Authors:  David T White; Meera T Saxena; Jeff S Mumm
Journal:  Adv Drug Deliv Rev       Date:  2019-02-12       Impact factor: 15.470

4.  Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.

Authors:  Fan Zhang; Panagiotis Mastorakos; Manoj K Mishra; Antonella Mangraviti; Lee Hwang; Jinyuan Zhou; Justin Hanes; Henry Brem; Alessandro Olivi; Betty Tyler; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2015-03-18       Impact factor: 12.479

5.  Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury.

Authors:  Elizabeth Nance; Michael Porambo; Fan Zhang; Manoj K Mishra; Markus Buelow; Rachel Getzenberg; Michael Johnston; Rangaramanujam M Kannan; Ali Fatemi; Sujatha Kannan
Journal:  J Control Release       Date:  2015-07-13       Impact factor: 9.776

6.  Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia.

Authors:  Christina L Nemeth; Gabrielle T Drummond; Manoj K Mishra; Fan Zhang; Patrice Carr; Maxine S Garcia; Sydney Doman; Ali Fatemi; Michael V Johnston; Rangaramanujam M Kannan; Sujatha Kannan; Mary Ann Wilson
Journal:  Nanomedicine       Date:  2017-06-30       Impact factor: 5.307

7.  Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.

Authors:  Bela R Turk; Christina L Nemeth; Joel S Marx; Carol Tiffany; Richard Jones; Benjamin Theisen; Siva Kambhampati; Raj Ramireddy; Sarabdeep Singh; Melissa Rosen; Miriam L Kaufman; Connor F Murray; Paul A Watkins; Sujatha Kannan; Rangaramanujam Kannan; Ali Fatemi
Journal:  Ann Neurol       Date:  2018-09       Impact factor: 10.422

8.  Nanotechnology Approaches to Targeting Inflammation and Excitotoxicity in a Canine Model of Hypothermic Circulatory Arrest-Induced Brain Injury.

Authors:  Joshua C Grimm; J Trent Magruder; Mary A Wilson; Mary E Blue; Todd C Crawford; Juan C Troncoso; Fan Zhang; Sujatha Kannan; Christopher M Sciortino; Michael V Johnston; Rangaramanujam M Kannan; William A Baumgartner
Journal:  Ann Thorac Surg       Date:  2016-05-04       Impact factor: 4.330

9.  Click hybridization of immune cells and polyamidoamine dendrimers.

Authors:  Leyuan Xu; Olga Yu Zolotarskaya; W Andrew Yeudall; Hu Yang
Journal:  Adv Healthc Mater       Date:  2014-02-13       Impact factor: 9.933

10.  Intracellular production of hydrogels and synthetic RNA granules by multivalent molecular interactions.

Authors:  Hideki Nakamura; Albert A Lee; Ali Sobhi Afshar; Shigeki Watanabe; Elmer Rho; Shiva Razavi; Allister Suarez; Yu-Chun Lin; Makoto Tanigawa; Brian Huang; Robert DeRose; Diana Bobb; William Hong; Sandra B Gabelli; John Goutsias; Takanari Inoue
Journal:  Nat Mater       Date:  2017-11-06       Impact factor: 43.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.